Toronto Dominion Bank’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.05M Sell
28,611
-260
-0.9% -$31.5K ﹤0.01% 1116
2026
Q1
$4.72M Sell
28,871
-7,435
-20% -$1.14M 0.01% 873
2025
Q4
$6.32M Buy
+36,306
New +$6.63M 0.01% 781
2022
Q4
– Sell
-68,646
Closed -$1.48M – 1551
2022
Q3
$1.48M Buy
+68,646
New +$1.65M ﹤0.01% 986

Other funds holding INSM

Toronto Dominion Bank's INSM Position: Q2 2026 in Review

Toronto Dominion Bank reduced its Insmed (INSM) stake by 0.9% in Q2 2026, selling an estimated $31.5K and leaving 28,611 shares worth $3.05M. The position accounts for ﹤0.01% of the portfolio, ranked #1116.

Toronto Dominion Bank first reported a position in INSM in Q3 2022 and has held it in 4 quarters since. The position peaked at $6.32M in Q4 2025. 667 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Toronto Dominion Bank held 28,611 shares of Insmed worth $3.05M as of Q2 2026.
  • Toronto Dominion Bank sold 260 Insmed shares in Q2 2026, an estimated $31.5K.
  • Insmed made up ﹤0.01% of Toronto Dominion Bank's portfolio in Q2 2026, its #1116 holding.
  • Toronto Dominion Bank first reported a position in Insmed in Q3 2022 and has held it in 4 quarters since.
  • Toronto Dominion Bank's Insmed position peaked at $6.32M in Q4 2025.
  • 667 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Toronto Dominion Bank's 13F filing for Q2 2026, filed 14 Aug 2026.